Health
Wellness, fitness, medicine, habits and everyday health guidance.
Fabry disease is a genetic condition caused by changes affecting the activity of the alpha galactosidase A enzyme. Reduced or absent enzyme activity can lead to the buildup of . . .
Fabry disease is a genetic condition that results from changes affecting an enzyme known as alpha galactosidase A. When this enzyme does not function properly, certain fatty substances can . . .
Fabry disease is a genetic condition caused by changes affecting the production or function of the alpha galactosidase A enzyme. Reduced or absent activity of this enzyme can lead . . .
Fabry disease is a genetic condition caused by changes that affect the activity of an enzyme responsible for breaking down a fatty substance in the body. When this substance . . .
Fabry disease is a genetic disorder caused by changes in the GLA gene, which affects the production or function of an enzyme called alpha galactosidase A. When this enzyme . . .
Alpha 1 Antitrypsin Deficiency is an inherited condition that may affect the lungs, liver, or both. The condition can vary considerably from person to person, so long term care . . .
Alpha 1 Antitrypsin Deficiency, often called Alpha 1 or AAT deficiency, is an inherited condition that can affect the lungs, liver, and, in some cases, other parts of the . . .
Alpha 1 Antitrypsin Deficiency is an inherited condition that may increase the risk of lung disease, particularly chronic obstructive pulmonary disease, and may also affect the liver. The condition . . .
Alpha 1 Antitrypsin Deficiency, often called AAT deficiency, is a genetic condition that affects the production or function of the alpha 1 antitrypsin protein. This protein is mainly produced . . .
Alpha 1 Antitrypsin Deficiency is a genetic condition in which the body does not produce enough functional alpha 1 antitrypsin, a protein that helps protect the lungs from damage. . . .